Average Co-Inventor Count = 3.37
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Intercept Pharmaceuticals, Inc. (15 from 62 patents)
15 patents:
1. 12337003 - Pharmaceutical compositions for combination therapy
2. 11311557 - Pharmaceutical compositions for combination therapy
3. 10987362 - Treatment of fibrosis using FXR ligands
4. 10894054 - FXR agonist compositions for combination therapy
5. 10758549 - Compositions of obeticholic acid and methods of use
6. 10751349 - Compositions of obeticholic acid and methods of use
7. 10646499 - Compositions of obeticholic acid and methods of use
8. 10258633 - Treatment of fibrosis using FXR ligands
9. 10052337 - Compositions of obeticholic acid and methods of use
10. 9763964 - Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
11. 9498484 - Treatment of fibrosis using FXR ligands
12. 9090652 - Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
13. 8546365 - Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
14. 7932244 - Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
15. 7858608 - Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions